The Office of the Chief Medical Officer (CMO) collaborates with colleagues throughout the company to ensure that we remain firm in our commitment to patient safety and well-being, and that we demonstrate this commitment in all of our decisions and actions.

Dr. Michael Rosenblatt, executive vice president and chief medical officer, leads this effort, representing an independent voice of patients and medicine within Merck and serving as the primary voice of Merck to the global scientific and medical community. He advises senior leadership and the Merck Board of Directors on key medical matters and also serves as the company's medical spokesperson, communicating with global health stakeholders, including the media and policy makers, about our products, our policy positions and other matters affecting patients.

Our CMO and his team collaborate with external scientists, academics and governments, sharing ideas and exchanging fresh insights so that Merck can better address global health challenges. Inside Merck, they provide medical and scientific perspective to inform R&D and commercial and corporate strategies, including our social responsibilities. The team also plays a direct role in fostering scientific transparency; establishing publication guidelines; providing medical reference information and education for physicians, other health professionals and consumers, and enhancing employee wellness.

In short, the CMO and his team play a unique role in helping Merck and our employees keep a sharp focus on patients in everything we do, building on our long-standing commitment to helping the world be well.